BRUKER CORP is 2.2x more valuable than 10x Genomics, Inc. by market capitalization ($8.36 B vs $3.72 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TXG | BRKR |
|---|---|---|
| Market cap | $3.72 B | $8.36 B |
| US-listed rank | #1634 | #1042 |
| Revenue (latest FY) | $642.82M | $3.44B |
| Net income (latest FY) | -$43.50M | -$8.30M |
| Net margin | -6.8% | -0.2% |
| SEC filings | 652 | 1,361 |
BRUKER CORP is 2.2x more valuable than 10x Genomics, Inc. by market capitalization ($8.36 B vs $3.72 B).
In their latest fiscal years, 10x Genomics, Inc. reported $642.82M in revenue while BRUKER CORP reported $3.44B.
Full pages: 10x Genomics, Inc. and BRUKER CORP, or browse the full rankings.